How Computational Biology is Transforming Drug R&D
Exchanges3 Maalis 2020

How Computational Biology is Transforming Drug R&D

The latest episode of Exchanges at Goldman Sachs premieres a new monthly feature: An examination of a topic at the center of conversations in the venture-capital community. This week, Goldman Sachs Research’s Heath Terry explores the growing world of computational biology—using the power of big data to revolutionize drug discovery, disease prevention and cancer detection. Terry talked to VCs like Lux Capital’s Zavain Dar, who invests in emerging science and technology firms. “It feels like we’re at the precipice of what I think will be a multi-decade revolution in how biology and chemistry are fundamentally practiced,” explains Dar. Terry also spoke with James Field, CEO of computational-biology startup LabGenius, which is using machine learning to more easily identify useful proteins for the human body. “If we can deploy technology in building out some discovery platforms in a way that the learnings compound over time,” says Field, “then it will dramatically change the economics of discovering and developing drug molecules.” Learn more about your ad choices. Visit megaphone.fm/adchoices

Jaksot(610)

Iran Conflict: How Long, and How Bad?

Iran Conflict: How Long, and How Bad?

The Iran conflict has triggered the largest energy supply disruption in history with shipping traffic in the Strait of Hormuz nearly at a standstill and regional energy infrastructure under fire. In t...

27 Maalis 19min

Private Credit Concerns in Context

Private Credit Concerns in Context

Goldman Sachs’ Alex Blostein and Vivek Bantwal discuss the market sentiment, fundamentals, and the outlook for the private credit sector. This episode was recorded on March 19th and 20th. The opin...

23 Maalis 30min

Lloyd Blankfein on His Memoir Streetwise, Risk Management and Leadership

Lloyd Blankfein on His Memoir Streetwise, Risk Management and Leadership

Goldman Sachs’ culture has long been defined by its core values: partnership, client service, integrity, and excellence. Lloyd Blankfein, Senior Chairman of The Goldman Sachs Group Inc. and former Cha...

20 Maalis 30min

Emerging Markets: Stirred, But Not Yet Shaken

Emerging Markets: Stirred, But Not Yet Shaken

Goldman Sachs Research’s Kamakshya Trivedi analyzes the market’s reaction to the conflict in Iran and the case for emerging markets. This episode was recorded on March 12, 2026. The opinions and v...

18 Maalis 14min

Goldman Sachs International’s Co-CEOs on Europe’s Opportunity, AI, and Market Volatility

Goldman Sachs International’s Co-CEOs on Europe’s Opportunity, AI, and Market Volatility

Goldman Sachs International Co-CEOs Anthony Gutman and Kunal Shah discuss CEO sentiment, market volatility, and the case for Europe. This episode was recorded on March 12, 2026. The opinions and vi...

16 Maalis 27min

Can Software Survive AI?

Can Software Survive AI?

Goldman Sachs Research’s Gabriela Borges explains how AI disruption has been affecting the software sector and what it will take for the sector to stabilize. For more, also read the related Goldman Sa...

10 Maalis 15min

Oil Market Impacts from Iran

Oil Market Impacts from Iran

Goldman Sachs Research’s Daan Struyven, co-head of Global Commodities Research and Head of Oil Research, discusses how the strikes in Iran could affect the oil market, commodities, and energy prices....

2 Maalis 13min

Why Japanese Stocks Could Keep Rallying

Why Japanese Stocks Could Keep Rallying

Goldman Sachs Research’s Bruce Kirk discusses the implications of Japan’s recent snap election and the implications for the equity market and foreign investors.  Date of recording: February 19, 2026....

24 Helmi 18min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
herrasmieshakkerit
rss-rahamania
ostan-asuntoja-podcast
leadcast
rss-lahtijat
rss-seuraava-potilas
rss-merja-mahkan-rahat
rss-40-ajatusta-aanesta
rahapuhetta
rss-porssipuhetta
rss-vaikuttavan-opettajan-vierella
rss-bisnesta-bebeja
rss-paatos-podcast-suomen-kovimmat-paatoksentekijat-2
rss-bisneksen-pehmea-puoli
rss-levosta-kasin-yrittajyys
rss-ma